Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

A COMPARISON OF THE ADRENERGIC RECEPTOR BLOCKING PROPERTIES OF 1-(4'-METHYLPHENYL)-2-ISOPROPYLAMINO-PROPANOL-HCl AND PROPRANOLOL

Bernard Levy
Journal of Pharmacology and Experimental Therapeutics June 1967, 156 (3) 452-462;
Bernard Levy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The effects of 1-(4'-methylphenyl)-2-isopropylamino-propanol-HCl (H 35-25) treatment on a number of adrenergic responses to isoproterenol were determined in the anesthetized dog and the isolated rat uterus. H 35-25 was compared, quantitatively, to propranolol in the anesthetized dog studies. Studies in the dog included the effects of treatment with H 35-25 and propranolol, in a dose range of 0.1 to 3.0 mg/kg, upon the positive inotropic, positive chronotropic, vasodilator, blood pressure and intestinal inhibitory responses to isoproterenol. Studies with the isolated, spontaneously contracting rat uterus consisted of a determination of both the intrinsic action of H 35-25 and its ability to modify the rat uterine inhibitory response to isoproterenol. Propranolol blocked all of the responses to isoproterenol in the anesthetized dog, simultaneously, in the same dose range (0.1-1.0 mg/kg). H 35-25 produced a blockade of the vasodilator and blood pressure responses to isoproterenol in a dose range of 0.3 to 1.0 mg/kg but did not block the positive inotropic, positive chronotropic or intestinal inhibitory responses to isoproterenol. In the rat uterus, H 35-25 produced an intrinsic inhibitory response which was abolished by propranolol. H 35-25 was also capable of blocking the rat uterine inhibitory response to isoproterenol. H 35-25 appears to be capable of producing a selective blockade of vascular beta receptors in a dose range that has little blocking action on cardiac beta receptors.

Footnotes

    • Received September 30, 1966.
    • Accepted January 16, 1967.
  • © 1967 by The Williams & Wilkins Company

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 156, Issue 3
1 Jun 1967
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A COMPARISON OF THE ADRENERGIC RECEPTOR BLOCKING PROPERTIES OF 1-(4'-METHYLPHENYL)-2-ISOPROPYLAMINO-PROPANOL-HCl AND PROPRANOLOL
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

A COMPARISON OF THE ADRENERGIC RECEPTOR BLOCKING PROPERTIES OF 1-(4'-METHYLPHENYL)-2-ISOPROPYLAMINO-PROPANOL-HCl AND PROPRANOLOL

Bernard Levy
Journal of Pharmacology and Experimental Therapeutics June 1, 1967, 156 (3) 452-462;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

A COMPARISON OF THE ADRENERGIC RECEPTOR BLOCKING PROPERTIES OF 1-(4'-METHYLPHENYL)-2-ISOPROPYLAMINO-PROPANOL-HCl AND PROPRANOLOL

Bernard Levy
Journal of Pharmacology and Experimental Therapeutics June 1, 1967, 156 (3) 452-462;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Antagonist-Induced Reversal of Functional and Structural Measures of Hippocampal Benzodiazepine Tolerance
  • Interaction of Diclofenac and Quinidine in Monkeys: Stimulation of Diclofenac Metabolism
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics